| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.54B | +12.1% |
| Cost of Revenue | $279.8M | +3.1% |
| Gross Profit | $2.26B | +13.3% |
| R&D Expense | $528.0M | +6.7% |
| SG&A Expense | $995.3M | +16.4% |
| Operating Income | $717.9M | +14.7% |
| Interest Expense | $47.8M | +1.5% |
| Pre-tax Income | $718.0M | +21.3% |
| Income Tax | $142.3M | +55.2% |
| Net Income | $575.7M | +15.0% |
| EPS (Basic) | $6.59 | +14.4% |
| EPS (Diluted) | $6.55 | +14.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $50.8M | — |
| Accounts Receivable | $1.02B | +18.3% |
| Current Assets | $2.83B | +38.2% |
| Total Assets | $8.05B | +9.9% |
| Current Liabilities | $941.2M | +5.8% |
| Long-term Debt | $755.0M | +0.0% |
| Stockholders' Equity | $6.09B | +12.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $795.7M | +11.0% |
| Investing Cash Flow | -$99.6M | +58.5% |
| Financing Cash Flow | -$98.5M | +57.4% |